SE429044B - Analogiforfarande for framstellning av imidazo-pyridiniumsalter - Google Patents

Analogiforfarande for framstellning av imidazo-pyridiniumsalter

Info

Publication number
SE429044B
SE429044B SE7609719A SE7609719A SE429044B SE 429044 B SE429044 B SE 429044B SE 7609719 A SE7609719 A SE 7609719A SE 7609719 A SE7609719 A SE 7609719A SE 429044 B SE429044 B SE 429044B
Authority
SE
Sweden
Prior art keywords
ingredients
preparation
analogy procedure
imidazo pyridine
imidazo
Prior art date
Application number
SE7609719A
Other languages
English (en)
Swedish (sv)
Other versions
SE7609719L (sv
Inventor
D E Kuhla
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7609719L publication Critical patent/SE7609719L/xx
Publication of SE429044B publication Critical patent/SE429044B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/48Aldehydo radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7609719A 1975-09-03 1976-09-02 Analogiforfarande for framstellning av imidazo-pyridiniumsalter SE429044B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60991475A 1975-09-03 1975-09-03

Publications (2)

Publication Number Publication Date
SE7609719L SE7609719L (sv) 1977-03-04
SE429044B true SE429044B (sv) 1983-08-08

Family

ID=24442870

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7609719A SE429044B (sv) 1975-09-03 1976-09-02 Analogiforfarande for framstellning av imidazo-pyridiniumsalter

Country Status (15)

Country Link
US (1) US4163745A (de)
JP (1) JPS5233693A (de)
AT (1) AT357158B (de)
BE (1) BE845767A (de)
CA (1) CA1063115A (de)
DE (1) DE2634910C3 (de)
DK (1) DK396676A (de)
ES (1) ES451175A1 (de)
FR (1) FR2322597A1 (de)
GB (1) GB1519717A (de)
IE (1) IE43313B1 (de)
LU (1) LU75719A1 (de)
MX (1) MX4817E (de)
NL (1) NL7609772A (de)
SE (1) SE429044B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1173196B (it) * 1984-02-02 1987-06-18 Bellon Roger Schoum Rbs Pharma Composti imidazopiridinici farmacologicamente attivi
EP0375819A1 (de) * 1988-12-20 1990-07-04 Merrell Dow Pharmaceuticals Inc. 1,7'-[Imidazo-[1,2-a]pyridin]5'-(6'H)one-Derivate
AU2003248246A1 (en) * 2002-06-25 2004-01-06 Kyowa Hakko Kogyo Co., Ltd. Hetero-bicyclic compounds
ES2522717B1 (es) * 2013-05-14 2015-06-24 Universidad De Alcalá Nuevos compuestos inhibidores de la proteina tirosina fosfatasa 1B

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1964282U (de) 1967-04-01 1967-07-20 Purrmann & Herr G M B H Wandler.
US3557114A (en) 1968-12-23 1971-01-19 Merck & Co Inc 1-substituted-3-(2-pyrimidinyl) imidazolium salts

Also Published As

Publication number Publication date
MX4817E (es) 1982-10-20
CA1063115A (en) 1979-09-25
ATA653976A (de) 1979-11-15
DK396676A (da) 1977-03-04
IE43313B1 (en) 1981-01-28
DE2634910B2 (de) 1979-11-22
ES451175A1 (es) 1977-09-01
IE43313L (en) 1977-03-03
DE2634910C3 (de) 1980-08-14
US4163745A (en) 1979-08-07
BE845767A (fr) 1977-03-02
NL7609772A (nl) 1977-03-07
LU75719A1 (de) 1977-06-15
GB1519717A (en) 1978-08-02
AT357158B (de) 1980-06-25
DE2634910A1 (de) 1977-03-10
FR2322597B1 (de) 1980-04-25
FR2322597A1 (fr) 1977-04-01
JPS5437158B2 (de) 1979-11-13
SE7609719L (sv) 1977-03-04
JPS5233693A (en) 1977-03-14

Similar Documents

Publication Publication Date Title
SE433208B (sv) Forfarande for framstellning av fenoletrar
SE422941B (sv) Analogiforfarande for framstellning av tetracykliska pyrido-bensazepinforeningar
SE434398B (sv) Analogiforfarande for framstellning av pyrido(2,1-b)kinazolinoner
SE422799B (sv) Analogiforfarande for framstellning av 1,3-dihydroimidazo (4,5-b)pyridin-2-oner
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
SE7611280L (sv) Forfarande for framstellning av 3-hydroxi-3-cefemestersulfoxider
SE427839B (sv) Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider
NO146058C (no) Analogifremgangsmaate for fremstilling av substituerte benzamider
SE432763B (sv) Forfarande for framstellning av nya homoftalimider
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
SE429044B (sv) Analogiforfarande for framstellning av imidazo-pyridiniumsalter
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
NO144739C (no) Fremgangsmaate for fremstilling av presset torvsubstrat
SE435715B (sv) Forfarande for framstellning av nya penicilliner
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE423814B (sv) Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
SE7604669L (sv) Forfarande for framstellning av estrar av tiokarbamidsyror
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner
SE427840B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE427109B (sv) Forfarande for framstellning av 16-fluorsubstituerade prostaglandinderivat
SE7604940L (sv) Forfarande for framstellning av sulfamylbensoesyror